Cytoreductive Surgery and HIPEC
Cytoreductive surgery (CRS) and HIPEC hyperthermic chemotherapy for peritoneal cancer treatment. 50-90% survival in colorectal, gastric, ovarian cancers.
Cytoreductive surgery (CRS) and HIPEC hyperthermic chemotherapy for peritoneal cancer treatment. 50-90% survival in colorectal, gastric, ovarian cancers.